Your browser doesn't support javascript.
loading
Exploiting RIG-I-like receptor pathway for cancer immunotherapy.
Jiang, Yangfu; Zhang, Hongying; Wang, Jiao; Chen, Jinzhu; Guo, Zeyu; Liu, Yongliang; Hua, Hui.
Afiliação
  • Jiang Y; Laboratory of Oncogene, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China. jyangfu@scu.edu.cn.
  • Zhang H; Laboratory of Oncogene, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Wang J; School of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, China.
  • Chen J; Laboratory of Oncogene, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Guo Z; Laboratory of Oncogene, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Liu Y; Laboratory of Oncogene, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Hua H; Laboratory of Stem Cell Biology, West China Hospital, Sichuan University, Chengdu, 610041, China. huahuihx@scu.edu.cn.
J Hematol Oncol ; 16(1): 8, 2023 02 08.
Article em En | MEDLINE | ID: mdl-36755342
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunidade Inata / Neoplasias Limite: Humans Idioma: En Revista: J Hematol Oncol Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunidade Inata / Neoplasias Limite: Humans Idioma: En Revista: J Hematol Oncol Ano de publicação: 2023 Tipo de documento: Article